Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Over the last 12 months, insiders at Avadel Pharmaceuticals plc have bought $722,035 and sold $0 worth of Avadel Pharmaceuticals plc stock.
On average, over the past 5 years, insiders at Avadel Pharmaceuticals plc have bought $939,312 and sold $1.52M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Ende Eric J (director) — $470,436. Glass Geoffrey Michael (director) — $199,641. Divis Gregory J (Chief Executive Officer) — $99,707.
The last purchase of 30,000 shares for transaction amount of $235,218 was made by Ende Eric J (director) on 2025‑01‑13.
2025-01-13 | director | 30,000 0.0321% | $7.84 | $235,218 | +2.62% | |||
2025-01-13 | director | 10,000 0.011% | $8.04 | $80,450 | +2.62% | |||
2024-12-13 | Chief Financial Officer | 2,300 0.0024% | $10.44 | $24,019 | +1.16% | |||
2024-12-11 | Chief Financial Officer | 5,000 0.0052% | $10.49 | $52,433 | +1.84% | |||
2024-12-10 | director | 20,279 0.0208% | $9.84 | $199,641 | +5.05% | |||
2024-12-09 | Chief Executive Officer | 402 0.0004% | $9.82 | $3,948 | +3.45% | |||
2024-12-06 | director | 3,000 0.0031% | $10.19 | $30,568 | +4.45% | |||
2024-12-06 | Chief Executive Officer | 9,598 0.0098% | $9.98 | $95,759 | +4.45% | |||
2024-01-16 | Chief Financial Officer | 2,000 0.0021% | $14.50 | $29,000 | +1.45% | |||
2023-12-28 | Sale | director | 75,000 0.0802% | $14.53 | $1.09M | +3.15% | ||
2023-08-14 | Chief Financial Officer | 2,000 0.0027% | $14.45 | $28,900 | +3.32% | |||
2023-08-11 | Sale | director | 28,975 0.0388% | $14.93 | $432,614 | -1.05% | ||
2023-08-10 | Chief Executive Officer | 10,000 0.0128% | $13.20 | $131,997 | +7.26% | |||
2023-08-10 | director | 14,000 0.0182% | $13.40 | $187,600 | +7.26% | |||
2023-05-18 | director | 13,000 0.0207% | $13.93 | $181,100 | +2.60% | |||
2023-05-09 | director | 2,500 0.0038% | $14.76 | $36,900 | -6.72% | |||
2022-12-23 | director | 2,000 0.0033% | $7.20 | $14,405 | +61.03% | |||
2022-11-29 | Chief Financial Officer | 5,000 0.008% | $7.80 | $39,000 | +36.61% | |||
2022-11-22 | director | 20,000 0.0314% | $7.80 | $156,050 | +32.02% | |||
2022-06-01 | 45,000 0.068% | $2.14 | $96,300 | +191.25% |
Ende Eric J | director | 208900 0.2168% | $7.75 | 10 | 0 | +59% |
Thornton Peter J. | director | 104055 0.108% | $7.75 | 3 | 0 | +78.3% |
MCHUGH THOMAS S | Chief Financial Officer | 87800 0.0911% | $7.75 | 9 | 0 | +48.83% |
Glass Geoffrey Michael | director | 75904 0.0788% | $7.75 | 9 | 0 | +72.31% |
Palczuk Linda | director | 66400 0.0689% | $7.75 | 6 | 0 | +51.17% |
Divis Gregory J | Chief Executive Officer | 10000 0.0104% | $7.75 | 8 | 0 | +31.52% |
Broadfin Healthcare Master Fund Ltd | 10 percent owner | 4133464 4.2895% | $7.75 | 0 | 2 | |
Flynn James E | 10 percent owner | 952265 0.9882% | $7.75 | 0 | 1 | |
STAPLETON CRAIG R | director | 323413 0.3356% | $7.75 | 12 | 1 | <0.0001% |
ANDERSON MICHAEL S | Chief Executive Officer | 248953 0.2584% | $7.75 | 11 | 1 | <0.0001% |
THOMPSON PHILLANDAS T. | See Remarks | 91000 0.0944% | $7.75 | 3 | 0 | <0.0001% |
McCamish Mark Anthony | director | 67025 0.0696% | $7.75 | 2 | 2 | +28.91% |
Hatten Sandra L | See Remarks | 55765 0.0579% | $7.75 | 4 | 3 | <0.0001% |
KANAN MICHAEL F | See Remarks | 29538 0.0307% | $7.75 | 1 | 1 | <0.0001% |
CERUTTI GUILLAUME | director | 23440 0.0243% | $7.75 | 0 | 1 | |
FILDES FRANCIS | director | 15000 0.0156% | $7.75 | 0 | 1 | |
GUSKY DAVID P | Controller & CAO | 4083 0.0042% | $7.75 | 0 | 1 |
Janus Henderson | $218.18M | 13.44 | 12.92M | +16.09% | +$30.24M | 0.11 | |
RTW Investments, LP | $148.61M | 9.15 | 8.8M | +26.64% | +$31.26M | 2.23 | |
Polar Capital | $114.07M | 7.03 | 6.75M | +0.03% | +$31,922.10 | 0.63 | |
Vivo Capital | $67.09M | 4.13 | 3.97M | -3.04% | -$2.1M | 5.84 | |
Braidwell Lp | $45.07M | 2.78 | 2.67M | New | +$45.07M | 2.55 | |
Wealth Effects Llc | $38.24M | 2.36 | 2.26M | -6.29% | -$2.57M | 5.63 | |
Adage Capital Partners Gp L L C | $32.28M | 1.99 | 1.91M | +749.33% | +$28.48M | 0.06 | |
Millennium Management LLC | $30.61M | 1.89 | 1.81M | +786.07% | +$27.16M | 0.02 | |
Citadel Advisors LLC | $26.41M | 1.63 | 1.56M | +155.04% | +$16.06M | 0.02 | |
Woodline Partners LP | $25.34M | 1.56 | 1.5M | -19% | -$5.94M | 0.22 | |
Brandes Investment Partners | $24.7M | 1.52 | 1.46M | -4.66% | -$1.21M | 0.32 | |
Tri Locum Partners Lp | $20.09M | 1.24 | 1.19M | +41.62% | +$5.9M | 1.66 | |
Tang Capital Management, LLC | $17.69M | 1.09 | 1.05M | -2.99% | -$544,753.18 | 0.07 | |
Samsara Biocapital Llc | $16.34M | 1.01 | 967,527 | 0% | +$0 | 2.55 | |
Bioimpact Capital Llc | $14.71M | 0.91 | 871,149 | +31% | +$3.48M | 2.38 | |
Elequin Securities Llc | $11.64M | 0.71 | 686,606 | New | +$11.64M | 0.45 | |
Penn Capital Management Co Inc | $11.64M | 0.71 | 686,606 | New | +$11.64M | 0.45 | |
Morgan Stanley | $11.24M | 0.69 | 665,411 | -32.92% | -$5.52M | <0.01 | |
Kennedy Capital Management Inc | $11.03M | 0.68 | 653,147 | +1.13% | +$122,840.97 | 0.23 | |
Modera Wealth Management | $10.14M | 0.63 | 600,449 | +0.34% | +$34,742.73 | 0.17 | |
Tupelo Capital Management LLC | $10.13M | 0.62 | 600,000 | 0% | +$0 | 0.25 | |
Deutsche Bank | $9.54M | 0.59 | 565,000 | +28.41% | +$2.11M | <0.01 | |
Altium Capital Management Lp | $9.34M | 0.58 | 553,057 | New | +$9.34M | 1.1 | |
Ally Bridge Group | $9.24M | 0.57 | 547,036 | +57.63% | +$3.38M | 5.2 | |
Renaissance Technologies | $6.86M | 0.42 | 406,006 | -35.05% | -$3.7M | 0.01 | |
New York State Common Retirement Fund | $6.75M | 0.42 | 399,551 | New | +$6.75M | 0.01 | |
Parkman Healthcare Partners Llc | $6.55M | 0.4 | 387,770 | New | +$6.55M | 0.82 | |
Goldman Sachs | $6.32M | 0.39 | 374,203 | -23.2% | -$1.91M | <0.01 | |
Schonfeld Group | $5.44M | 0.34 | 322,000 | New | +$5.44M | 0.03 | |
Kairos Capital Management Lp | $5.38M | 0.33 | 318,240 | New | +$5.38M | 2.57 | |
Balyasny Asset Management Llc | $5.23M | 0.32 | 309,712 | -60.37% | -$7.97M | 0.01 | |
Ameriprise Financial | $4.92M | 0.3 | 291,274 | +0.75% | +$36,482.40 | <0.01 | |
Obermeyer Wood Investment Counsel LLLP | $4.72M | 0.29 | 279,494 | New | +$4.72M | 0.28 | |
Hudson Bay Capital Management LP | $4.21M | 0.26 | 249,160 | New | +$4.21M | 0.03 | |
Lord Abbett | $3.26M | 0.2 | 193,233 | New | +$3.26M | 0.01 | |
Cubist Systematic Strategies | $2.85M | 0.18 | 168,528 | +1,722.52% | +$2.69M | 0.03 | |
Schulhoff Co Inc | $2.31M | 0.14 | 137,000 | +42.71% | +$692,490.00 | 1.06 | |
Dorsey Wright Associates | $2.16M | 0.13 | 127,640 | New | +$2.16M | 0.57 | |
Jump Financial Llc | $2.13M | 0.13 | 126,000 | +532.78% | +$1.79M | 0.02 | |
Royal Bank of Canada | $2.07M | 0.13 | 122,565 | +3,328.39% | +$2.01M | <0.0001 | |
Russell Investments Group Ltd | $1.94M | 0.12 | 115,041 | New | +$1.94M | <0.01 | |
CETERA INVESTMENT ADVISERS LLC | $1.93M | 0.12 | 113,978 | New | +$1.93M | <0.01 | |
MAI Capital Management, LLC | $1.89M | 0.12 | 111,605 | +4.23% | +$76,427.23 | 0.02 | |
Geode Capital Management | $1.76M | 0.11 | 104,227 | +12.58% | +$196,667.16 | <0.0001 | |
Mml Investors Services Llc | $1.72M | 0.11 | 101,931 | +36.12% | +$456,976.78 | 0.01 | |
Cetera Advisors LLC | $1.55M | 0.1 | 92,017 | +8.91% | +$127,198.58 | 0.01 | |
Investors Asset Management Of Georgia Inc Ga Adv | $1.48M | 0.09 | 87,375 | -17.94% | -$322,599.05 | 0.71 | |
Lion Point Capital LP | $1.39M | 0.09 | 82,500 | +3.13% | +$42,225.00 | 2.7 | |
D. E. Shaw & Co. | $1.39M | 0.09 | 82,109 | -58.23% | -$1.93M | <0.01 | |
BlackRock | $1.29M | 0.08 | 76,442 | -6.24% | -$85,970.14 | <0.0001 |